chloroquin
prophylact
agent
chloroquin
antimalari
drug
shown
effect
vitro
novel
coronaviru
formerli
name
vero
cell
effect
concentr
ec
ec
hydroxychloroquin
use
autoimmun
diseas
rheumatoid
arthriti
lupu
also
demonstr
vitro
antivir
activ
caus
coronaviru
diseas
ec
hydroxychloroquin
found
potent
chloroquin
phosphat
ec
chloroquin
hydroxychloroquin
seem
inhibit
fusion
viru
cell
membran
modul
endosom
ph
drug
also
inhibit
nucleic
acid
replic
twenti
three
clinic
trial
conduct
china
investig
efficaci
safeti
chloroquin
hydroxychloroquin
treatment
chloroquin
phosphat
demonstr
mark
efficaci
treatment
sever
advers
reaction
patient
shorten
hospit
stay
improv
clinic
evolut
find
led
chines
expert
recommend
state
patient
mild
moder
sever
case
without
chloroquin
contraind
treat
chloroquin
phosphat
dose
mg
twice
per
day
day
preliminari
clinic
data
show
hydroxychloroquin
mg
daili
cure
patient
day
first
drug
intak
efficaci
hydroxychloroquin
improv
combin
azithromycin
azithromycin
antibiot
antivir
properti
demonstr
rnavirus
zika
viru
patient
treat
hydroxychloroquin
associ
azithromycin
mg
day
follow
mg
per
day
next
day
virolog
cure
day
comparison
patient
treat
hydroxychloroquin
without
treatment
result
promis
supplement
larger
number
observ
importantli
therapeut
intervent
use
high
dosag
chloroquin
andor
combin
macrolid
may
frequent
report
side
effect
chloroquineproguanil
epigastralgia
diarrhea
nausea
longterm
chimioprophylaxi
nonimmun
soldier
durat
month
combin
chloroquin
antibiot
doxycyclin
daili
prophylaxi
increas
risk
advers
effect
european
countri
also
recommend
mg
chloroquin
weekli
alon
combin
proguanil
mg
daili
gastrointestin
side
effect
observ
longterm
preval
lower
observ
chloroquineproguanil
daili
world
health
organ
recommend
maximum
durat
year
continu
use
mg
chloroquin
base
weekli
year
mg
daili
dose
g
chloroquin
base
exceed
annual
ophthalmolog
examin
recommend
addit
chloroquin
rapidli
dealkyl
antiplasmodi
activ
desethychloroquin
via
cytochrom
enzym
chloroquin
desethylchloroquin
concentr
declin
slowli
elimin
halfliv
day
promis
result
chloroquin
treatment
low
preval
side
effect
longterm
use
suggest
possibl
use
chloroquin
mg
daili
hydroxychloroquin
mg
weekli
mass
prophylaxi
peopl
expos
could
part
urgent
intervent
current
requir
help
protect
healthcar
worker
combat
frontlin
chemoprophylaxi
chloroquin
hydroxychloroquin
could
prevent
associ
pneumonia
block
transmiss
reduc
number
asymptomat
carrier
propos
use
chloroquin
load
dose
mg
follow
mg
daili
chloroquin
use
pregnant
women
three
trimest
pregnanc
breastfeed
women
prophylaxi
chloroquin
contraind
patient
sever
renal
hepat
diseas
prophylact
dose
reduc
patient
mild
moder
failur
avoid
drug
accumul
clinic
doubleblind
random
placebocontrol
trial
initi
may
evalu
potenti
prevent
chloroquin
load
dose
mg
base
kg
follow
mg
chloroquin
base
mg
chloroquin
phosphat
salt
daili
month
healthcar
worker
individu
signific
risk
averag
particip
per
site
recruit
site
number
episod
symptomat
sever
symptom
durat
ill
number
symptomat
respiratori
infect
number
asymptomat
infect
record
compar
subject
randomis
chloroquin
placebo
month
followup
compet
interest
author
conflict
interest
declar
ethic
approv
requir
